Hello, IUPHARcurators, and welcome to Wikipedia! Thank you for your contributions. I hope you like the place and decide to stay. Here are some pages that you might find helpful:
I hope you enjoy editing here and being a
Wikipedian! Please
sign your messages on
talk pages using four
tildes (~~~~); this will automatically insert your username and the date. If you need help, check out
Wikipedia:Questions, ask me on
my talk page, or ask your question on this page and then place {{help me}}
before the question. Again, welcome!
Lone boatman (
talk)
15:08, 16 August 2012 (UTC)
Hello, I'm
Lone boatman. I noticed that you recently removed some content without explaining why. In the future, it would be helpful to others if you described your changes to Wikipedia with an
edit summary. The removed content has been restored. If you think I made a mistake, or if you have any questions, you can leave me a message on
my talk page. Thanks,
Lone boatman (
talk)
15:08, 16 August 2012 (UTC)
Hi I see that you are removing ligand IDs from articles, but I am checking against the IUPHAR database and it looks like you are removing correct information. Can you please explain what you are doing??
Zad
68
15:18, 16 August 2012 (UTC)
Please do not remove content or templates from pages on Wikipedia, as you did to
Epinephrine with
this edit, without giving a valid reason for the removal in the
edit summary. Your content removal does not appear constructive, and has been
reverted. Please make use of the
sandbox if you'd like to experiment with test edits. Thank you.
Zad
68
15:19, 16 August 2012 (UTC)
Hi, I am one of the curators for the IUPHAR database and I have identified that the links I have removed from the articles are linking to the incorrect ligand pages on IUPHAR-DB
Zad
68
15:55, 16 August 2012 (UTC)
![]() |
Hi IUPHARcurators! Thanks for contributing to Wikipedia. Please join other people who edit Wikipedia at the Teahouse! The Teahouse is a friendly space on Wikipedia where new editors can ask questions about contributing to Wikipedia and get help from peers and experienced editors. I hope to see you there! SarahStierch ( I'm a Teahouse host) This message automatically delivered by your friendly neighborhood HostBot ( talk) 04:29, 17 August 2012 (UTC) |
Thanks for uploading
File:Guide to PHARMACOLOGY logo.jpg. The media description page currently specifies that it is non-free and may only be used on Wikipedia under a
claim of fair use. However, it is currently
orphaned, meaning that it is not used in any articles on Wikipedia. If the media was previously in an article, please go to the article and see why it was removed.
You may add it back if you think that will be useful. However, please note that media for which a replacement could be created are not acceptable for use on Wikipedia (see
our policy for non-free media).
If you have uploaded other unlicensed media, please check whether they're used in any articles or not. You can find a list of 'file' pages you have edited by clicking on the " my contributions" link (it is located at the very top of any Wikipedia page when you are logged in), and then selecting "File" from the dropdown box. Note that all non-free media not used in any articles will be deleted after seven days, as described on criteria for speedy deletion. Thank you. Hazard-Bot ( talk) 04:21, 30 March 2013 (UTC)
![]() |
Cochrane Collaboration is an independent medical nonprofit organization consisting of over 28,000 volunteers in more than 100 countries. The collaboration was formed to organize medical scholarship in a systematic way in the interests of evidence-based research: the group conducts systematic reviews of randomized controlled trials of health-care interventions, which it then publishes in the Cochrane Library.
Cochrane has generously agreed to give free, full-access accounts to 100 medical editors. Individual access would otherwise cost between $300 and $800 per account. Thank you Cochrane!
If you are stil active as a medical editor, come and sign up :)
Cheers, Ocaasi t | c 19:56, 16 June 2013 (UTC)
Thanks for uploading File:IUPHAR-DB small logo.png. The image description page currently specifies that the image is non-free and may only be used on Wikipedia under a claim of fair use. However, the image is currently not used in any articles on Wikipedia. If the image was previously in an article, please go to the article and see why it was removed. You may add it back if you think that that will be useful. However, please note that images for which a replacement could be created are not acceptable for use on Wikipedia (see our policy for non-free media).
Note that any non-free images not used in any articles will be deleted after seven days, as described in the criteria for speedy deletion. Thank you. Stefan2 ( talk) 14:56, 28 June 2014 (UTC)
Hello and
welcome to Wikipedia. When you add content to
talk pages and Wikipedia pages that have open discussion (but never when editing articles), please be sure to
sign your posts. There are two ways to do this. Either:
This will automatically insert a signature with your username or IP address and the time you posted the comment. This information is necessary to allow other editors to easily see who wrote what and when.
Thank you. -- SineBot ( talk) 13:51, 19 May 2015 (UTC)
Hi,
You appear to be eligible to vote in the current
Arbitration Committee election. The
Arbitration Committee is the panel of editors responsible for conducting the Wikipedia
arbitration process. It has the authority to enact binding solutions for disputes between editors, primarily related to serious behavioural issues that the community has been unable to resolve. This includes the ability to impose
site bans,
topic bans, editing restrictions, and other measures needed to maintain our editing environment. The
arbitration policy describes the Committee's roles and responsibilities in greater detail. If you wish to participate, you are welcome to
review the candidates' statements and submit your choices on
the voting page. For the Election committee,
MediaWiki message delivery (
talk)
16:56, 24 November 2015 (UTC)